AAV Market Size and Revenue Gains
Adeno-Associated Virus Vector-Based Gene Therapy Market
The global adeno-associated virus (AAV) vector-based gene therapy market is growing rapidly, valued at US$52 billion in 2023 and projected to grow at a CAGR of 23.2% from 2023 to 2030.
AAV in Asia Aviation
Asia Aviation Plc (AAV), the sole shareholder of Thai AirAsia, saw operational revenue gains in the third quarter of 2022 with 969% YoY and 76% QoQ.
AAV also made revenue gains in the first half of 2024 with a growing percentage of revenue coming from the East Coast.
Growth Drivers and Trends
The growth of the AAV market is driven by factors such as:
- Increasing prevalence of genetic disorders
- Advancements in gene editing technologies
- Government initiatives and funding
Key trends in the AAV market include:
- Development of novel AAV vectors with improved safety and efficacy
- Expansion of AAV applications to treat a wider range of diseases
- Increasing interest in gene therapy for personalized medicine
Industry Outlook
The future of the AAV market looks promising with potential breakthroughs in gene therapy leading to new treatment options for various diseases.
Continued research and development efforts, coupled with government support, are expected to drive the growth of the AAV market in the coming years.
Comments